Efficacy of recombinant Bacillus Calmette-Guérin containing dltA in in vivo three-dimensional bio-printed bladder cancer-on-a-chip and ex vivo orthotopic mouse model
Purpose: We investigated the efficacy and optimal dosage of recombinant Bacillus Calmette-Guérin-dltA (rBCG-dltA) in a high-throughput 3D bio-printed bladder cancer-on-a-chip (BCOC) and orthotopic bladder cancer mouse model. Materials and Methods: We fabricated high-throughput BCOC with microfluidi...
Main Authors: | Joongwon Choi, Tae Young Jung, Jung Hoon Kim, Sejung Maeng, Su Jeong Kang, Mirinae Kim, Young Wook Choi, Se Young Choi, Sung-Hwan Kim, In Ho Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Urological Association
2023-05-01
|
Series: | Investigative and Clinical Urology |
Subjects: | |
Online Access: | https://www.icurology.org/pdf/10.4111/icu.20220293 |
Similar Items
-
Clinical Course of Bacillus Calmette-Guerin Lymphadenitis
by: Dayoung Ko, et al.
Published: (2022-04-01) -
Comparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette–Guérin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective multicenter study
by: Joongwon Choi, et al.
Published: (2024-05-01) -
Next-Generation Vaccines Based on Bacille Calmette–Guérin
by: Natalie E. Nieuwenhuizen, et al.
Published: (2018-02-01) -
Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes.
by: Kathleen H Cox, et al.
Published: (2009-01-01) -
DltC acts as an interaction hub for AcpS, DltA and DltB in the teichoic acid d-alanylation pathway of Lactiplantibacillus plantarum
by: Nikos Nikolopoulos, et al.
Published: (2022-07-01)